Biochemical mechanisms of the metabolic syndrome and the role of magnesium

Magnesium Research

Volumn 23, Issue 3, 2010, Pages 142-145

  Günther, Theodor ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM;

ANIMAL; ARTICLE; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; HUMANS; HYPERTENSION; MAGNESIUM; METABOLIC SYNDROME X;

EID: 78149252746     PISSN: 09531424     EISSN: 19524021     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995; 75: 473-86.
2. Sanders TG, Huijgen HJ, Sanders R. Magnesium disease: a review with special emphasis on the serum ionized magnesium. Clin Chem Lab Med 1999; 37: 1011-33.
3. Kumeda Y, Inaba M. Review of magnesium and metabolic syndrome. In: Nishizawa Y, Morii H, Durlach J, eds. New perspectives in magnesium research. London: Springer Verlag, 2007: 189-96.
4. Giugliano D, Ceriello A, Paolisso G. Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress? Metabolism 1995; 44: 363-8.
5. Resnick LM. Ionic basis of hypertension, insulin resistance, vascular disease, and related disorders. The mechanism of "syndrome x". Am J Hypertens 1993; 6: 123S-134S.
6. El-Mallakh RS. Hypertension and diabetes in obesity: a review and new ideas on the contributing role of ions. Med Hypotheses 1986; 19: 47-55.
7. Zemel MB. Insulin resistance, obesity and hypertension: an overview. J Nutr 1995; 125: 1715S-1717S.
8. Levy J, Gavin JR III, Sowers JR. Diabetes mellitus: a disease of abnormal cellular calcium metabolism? Am J Med 1994; 96: 260-73.
9. Matuura T, Kohno M, Kanayama Y, Yasunari K, Murakawa K, Takeda T, Ishimori K, Morishima I, Yonezawa T. Decreased intracellular free magnesium in erythrocytes of spontaneously hypertensive rats. Biochem Biophys Res Commun 1987; 143: 1012-7.
10. Woods KL, Walmsley D, Heagerty AM, Turner DL, Lian L-Y. 31P nuclear magnetic resonance measurement of free erythrocyte magnesium concentration in man and its relation to blood pressure. Clin Sci 1988; 74: 513-7.
11. Laurant P, Touyz RM. Physiological and pathophysiological role of magnesium in the cardiovascular system: implications in hypertension. J Hypertens 2000; 18: 1177-91.
12. Delva P, Pastori C, Montesi G, Degan M, Micciolo R, Paluani F, Lechi A. Intralymphocyte free magnesium and calcium and insulin tolerance test in a group of essential hypertensive patients. Life Sci 1998; 63: 1405-15.
13. Sebekova K, Stefikova K, Spustova V, Dzurik R. 31P NMR investigation of free intracellular Mg, pH, and phosphate metabolism in skeletal muscle of patients with essential hypertension. In: Smetana R, ed. Advances in magnesium research:1. London: John Libbey, 1997: 183-9.
14. Jelicks LA, Gupta RK. NMR measurement of cytosolic free calcium, free magnesium, and intracellular sodium in the aorta of the normal and spontaneously hypertensive rat. J Biol Chem 1990; 265: 1394-400.
15. Altura BM, Altura BT, Gebrewold A, Ising H, Günther T. Magnesium deficiency and hypertension: correlation between magnesium-deficient diets and microcirculatory changes in situ. Science 1984; 223: 1315-7.
16. Altura BM, Altura BT, Gebrewold A, Ising H, Günther T. Noise-induced hypertension and magnesium in rats: relationship to microcirculation and calcium. J Appl Physiol 1992; 72: 194-202.
17. Zhang A, Cheng TPO, Altura BM. Magnesium regulates intracellular free ionized calcium concentration and cell geometry in vascular smooth muscle cells. Biochim Biophys Acta 1992; 1134: 25-9.
18. Saini HK, Tripathi ON, Zhang S, Elimban V, Dhalla NS. Involvement of Na+/Ca2+ exchanger in catecholamineinduced increase in intracellular calcium in cardiomyocytes. Am J Physiol 2006; 290: H373-H380.
19. Wilson FH, Hariri A, Farhi A, Zhao H, Petersen KF, Toka HR, Nelson-Williams C, Raja KM, Kashgarian M, Shulman GI, Scheinman SJ, Lifton RP. A cluster of metabolic defects caused by mutation in a mitochondrial tRNA. Science 2004; 306: 1190-4.
20. Günther T. The biochemical function of Mg2+ in insulin secretion, insulin signal transduction and insulin resistance. Magnes Res 2010; 23: 5-18.
21. Pöykkö SM, Kellokoski E, Hörkkö S, Kauma H, Kesäniemi YA, Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003; 52: 2546-53.
22. Alonso-Galicia M, Brands MW, Zappe DH, Hall JE. Hypertension in obese Zucker rats. Role of angiotensin II and adrenergic activity. Hypertension 1996; 28: 1047-54.
23. Zemel MB, Sowers JP, Shehin S, Walsh MF, Levy J. Impaired calcium metabolism associated with hypertension in Zucker obese rats. Metabolism 1990; 39: 704-8.
24. Zemel MB, Peuler JD, Sowers JR, Simpson L. Hypertension in insulin-resistant Zucker obese rats is independent of sympathetic neural support. Am J Physiol 1992; 262: E368-E71.
25. Dunn KM, Nelson MT. Calcium and diabetic vascular dysfunction. Focus on "elevated Ca2+ sparklet activity during acute hyperglycemia and diabetes in cerebral arterial smooth muscle cells". Am J Physiol 2010; 298: C203-C2C5.
26. Navedo MF, Takeda Y, Nieves-Cintrón M, Molkentin JD, Santana LF. Elevated Ca2+ sparklet activity during acute hyperglycemia and diabetes in cerebral arterial smooth muscle cells. Am J Physiol 2010; 298: C211-CC20.
27. Johnson EM, Theler J-M, Capponi AM, Vallotton MB. Characterization of oscillations in cytosolic free Ca2+ concentration and measurement of cytosolic Na+ concentration changes evoked by angiotensin II and vasopressin in individual rat aortic smooth muscle cells. J Biol Chem 1991; 266: 12618-26.
28. Schiffrin EL, Touyz RM. From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension. Am J Physiol 2004; 287: H435-HH46.
29. Touyz RM, Yao G. Inhibitors of Na+/Mg2+ exchange activity attenuate the development of hypertension in angiotensin II-induced hypertensive rats. J Hypertens 2003; 21: 337-44.
30. Touyz RM, Schiffrin EL. Activation of the Na+-H+ exchanger modulates angiotensin II-stimulated Na+-dependent Mg2+ transport in vascular smooth muscle cells in genetic hypertension. Hypertension 1999; 34: 442-9.
31. Touyz RM, Mercure C, Reudelhuber TL. Angiotensin II type I receptor modulates intracellular free Mg2+ in renally derived cells via Na+-dependent Ca2+-independent mechanisms. J Biol Chem 2001; 276: 13657-63.
32. Ebel H, Günther T. Na+/Mg2+ antiport in erythrocytes of spontaneously hypertensive rats: role of Mg2+ in the pathogenesis of hypertension. Magnes Res 2005; 18: 175-85.
33. Dixit MP, Xu L, Xu H, Bai L, Collins JF, Ghishan FK. Effect of angiotensin-II on renal Na+/H+ exchanger- NHE3 and NHE2. Biochim Biophys Acta 2004; 1664: 38-44.
34. Li H-Y, Quamme GA. Effect of pH on intracellular free Mg2+ in isolated adult rat cardiomyocytes. Biochim Biophys Acta 1994; 1222: 164-70.
35. Moor AN, Fliegel L. Protein kinase-mediated regulation of the Na+/H+ exchanger in the rat myocardium by mitogen-activated protein kinase-dependent pathways. J Biol Chem 1999; 274: 22985-92.
36. Ceolotto G, Conlin P, Clari G, Semplicini A, Canessa M. Protein kinase C and insulin regulation of red blood cell Na+/H+ exchange. Am J Physiol 1997; 272: C818-CC26.
37. Sartori M, Ceolotto G, Semplicini A. MAPkinase and regulation of the sodium-proton exchanger in human red blood cell. Biochim Biophys Acta 1999; 1421: 140-8.
38. Lijnen P, Echevaria-Vázquez D, Fagard R, Petrov V. Protein kinase C induced changes in erythrocyte Na+/H+ exchange and cytosolic free calcium in humans. Am J Hypertens 1998; 11: 81-7.
39. Bers DM, Barry WH, Despa S. Intracellular Na+ regulation in cardiac myocytes. Cardiovascular Res 2003; 57: 897-912.
40. Thomas T. Inhibitors of Na+/Mg2+ exchange activity attenuate the development of hypertension in angiotensin II-induced hypertensive rats. J Hypertens 2003; 21: 257-8.
41. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000; 18: 655-73.
42. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 2002; 82: 47-95.
43. Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension. Hypertension 2004; 44: 248-52.